September 4, 2026 STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study September 4, 2026 STAT+: Top Boston hospitals clash over Medicare Advantage network after split September 4, 2026 STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies September 4, 2026 Lawmakers to subpoena Oracle execs as EHR project costs rise September 4, 2026 STAT+: FDA takes another look at botanical drugs September 4, 2026 STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more September 4, 2026 Disabled workers at greater risk of losing health insurance September 4, 2026 Adena Health acquires Fairfield Medical Center after antitrust scrutiny September 4, 2026 Opinion: Make infectious disease data boring again September 4, 2026 STAT+: Lindsay Clancy case exposes dangers of fragmented U.S. health system, experts say September 4, 2026 Opinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains September 3, 2026 STAT+: Recipients of gene-edited pig kidneys successfully receive human organs September 3, 2026 STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder September 3, 2026 Why AI scribes are a malpractice risk, according to experts September 3, 2026 ‘Tactical athletes’ get new guidance for cardiovascular fitness September 3, 2026 HaloMD says No Surprises is lowering spending on emergency care. Researchers aren’t convinced. September 3, 2026 STAT+: Fauci speaks, and writes September 3, 2026 STAT+: Seattle scientists launch $95 million AI biology effort September 3, 2026 STAT+: We’re reading about an Ultragenyx failure, RevMed for lung cancer, and more September 3, 2026 STAT+: OpenEvidence launches new family of AI models September 3, 2026 HHS flip-flops on disability lawsuit September 3, 2026 STAT+: Abivax has still not been acquired. What’s going on? September 3, 2026 STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized September 3, 2026 Opinion: STAT+: A surprising bright spot at the FDA on regulating unproven stem cells September 3, 2026 Opinion: I was a doula before I was an OB-GYN. I wish the two professions understood each other more September 3, 2026 The pediatricians who take in vaccine-skeptical parents others won’t September 3, 2026 Why are drug overdose deaths declining? September 2, 2026 UnitedHealthcare cuts prior authorization from 1,700 codes September 2, 2026 Medicare spent hundreds of millions of dollars on ineligible drugs, audit finds September 2, 2026 STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial September 2, 2026 Johns Hopkins Health Plans taps interim CEO as it searches for successor September 2, 2026 DaVita agrees to pay $15M to settle claims from data breach September 2, 2026 McKesson confirms data theft in cyberattack involving third-party apps September 2, 2026 Doctors groups release vaccination guidelines ahead of respiratory illness season September 2, 2026 STAT+: Pharmalittle: We’re reading about a Huntington’s gene therapy, Novo’s challenges, and more September 2, 2026 STAT+: How a former ARPA-H director’s startup is tackling AI’s ‘dumb problems’ September 2, 2026 STAT+: ARPA-H funds biotechs working on custom RNA therapies September 2, 2026 HHS spins a tale of a would-be content creator child September 2, 2026 STAT+: How Trump’s latest pharma deals may undermine efforts to rein in drug costs September 2, 2026 STAT+: The Ig Nobel Prizes, long held in the U.S., head to Europe due to Trump policies 1 2 3 … 54 Next Page 2026-03-30
